Besremi

ropeginterferon alfa-2b-njft

Approval

ApplicationBLA 761166
Approval dateNov 12, 2021
Approval year2021
SponsorPharmaessentia CORP

FDA-approved use

To treat polycythemia vera, a blood disease that causes the overproduction of red blood cells

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Besremi: